v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning of period (in shares) at Dec. 31, 2024   82,734,696      
Balance, beginning of period at Dec. 31, 2024 $ 134,274 $ 8 $ 1,602,441 $ 268 $ (1,468,443)
Statement of Stockholders' Equity (Deficit)          
Issuance of common stock from at the market equity offering, net (in shares)   706,236      
Issuance of common stock from at-the-market equity offering, net 1,435   1,435    
Vesting of restricted common stock awards (in shares)   268,604      
Stock-based compensation expense 2,979   2,979    
Unrealized (loss) gain on marketable debt securities (180)     (180)  
Net loss (76,088)       (76,088)
Balance, end of period (in shares) at Mar. 31, 2025   83,709,536      
Balance, end of period at Mar. 31, 2025 62,420 $ 8 1,606,855 88 (1,544,531)
Balance, beginning of period (in shares) at Dec. 31, 2025   97,866,996      
Balance, beginning of period at Dec. 31, 2025 27,288 $ 10 1,655,781 0 (1,628,503)
Statement of Stockholders' Equity (Deficit)          
Vesting of restricted common stock awards (in shares)   34,038      
Stock-based compensation expense 2,102   2,102    
Unrealized (loss) gain on marketable debt securities 0        
Net loss (24,982)       (24,982)
Balance, end of period (in shares) at Mar. 31, 2026   97,901,034      
Balance, end of period at Mar. 31, 2026 $ 4,408 $ 10 $ 1,657,883 $ 0 $ (1,653,485)